Search

everythinglearnresearchcommunity

for

Search:↓

The mTOR pathway proteins are altered in the hair follicles of patients with Lichen Planopilaris and Frontal Fibrosing Alopecia.

Frontal fibrosing alopecia may be linked to genital Lichen sclerosus through an autoimmune process.

Low level laser therapy may help with hair loss.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

LLLT promotes hair growth and improves hair density safely in men and women.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Platelet lysate is more effective than activated autologous platelet-rich plasma or saline in improving hair growth after hair restoration surgery.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Low PON1 levels may indicate and predict the severity of hair loss.

The revised BASP classification for hair loss is less accurate and harder to use but could still be a viable option.

LLLT increases hair density and growth in AGA patients.

The thulium laser and PDRN injections effectively improved hair thickness in patients with pattern hair loss.

Linalool in personal care products may contribute to hair loss by damaging hair follicle stem cells and triggering harmful immune responses.

Patients with lichen planopilaris/frontal fibrosing alopecia have a higher rate of vitamin D deficiency than the general US population.

Localized hair growth and fat loss may share a common cause in lupus panniculitis.

Super-activated platelet lysate significantly promotes hair regrowth in mice with androgenetic alopecia.

Platelet-rich plasma injections can help treat hair loss in lupus patients.

The PIP5K1A gene helps cashmere growth in goats by promoting cell proliferation, and melatonin boosts its expression.

Lactilactobacillus curvatus LB-P9 taken orally helps hair regrow faster and thicker in mice.

Lash ptosis is more common and severe in people with congenital eyelid droop than in those with acquired eyelid droop or without eyelid droop.

People with lichen planopilaris often have seborrheic dermatitis, which can delay the diagnosis of lichen planopilaris.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

Targeting PTEN can improve healing in venous leg ulcers.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Lichen Planopilaris causes irreversible hair loss due to immune attacks on hair stem cells, but modulating PPAR-γ might help treat it.

Pruritus is common in LPP and FFA, worsened by heat and stress, and relieved by cold, affecting quality of life.

Your genes, especially IL-1a, can predict how well a hair growth treatment with platelet rich plasma will work for you.

Lower GPX4 mRNA levels are linked to higher disease activity and symptoms in lupus patients.